In early pregnant primates, relaxin (RLX) is highly upregulated within the corpus luteum (CL), suggesting that RLX may have an important role in the implantation of the blastocyst. Therefore, the aim of the present study was to investigate the local effects of RLX and gonadotrophins on the maintenance of the CL using an in vitro microdialysis system. CLs of common marmoset monkeys were collected by luteectomy during different stages of the luteal phase and early pregnancy. Each CL was perfused with either Ringer's solution alone or Ringer's solution supplemented with either porcine RLX (250, 500 and 1000 ng/ml) or gonadotrophins (50 IU/ml). Application of RLX provoked a significant luteal response of progesterone (P 4 ) and oestradiol (E 2 ) secretions during the mid-luteal phase (500 ng/ml: P 4 54G42%, E 2 24G11%; 1000 ng/ml: E 2 16G13%), and especially during the late luteal phase (250 ng/ml: P 4 53G10%; 500 ng/ml: P 4 44G15%; 1000 ng/ml: P 4 62G15%, E 2 18G7%). The effects of RLX on steroid secretion were irrespective of the RLX dosages. While treatment with human chorionic gonadotrophin did not affect luteal steroid or RLX secretion, the application of FSH resulted in a significant increase in the secretion of both P 4 (20G8%) and E 2 (37G28%), and a prominent rise in RLX during early pregnancy. In conclusion, our results demonstrate that RLX and FSH have a luteotrophic function in the marmoset monkeys; moreover, FSH has a function beyond its traditional role just as a follicle-stimulating hormone.
Introduction
In the common marmoset monkey (Callithrix jacchus), relaxin (RLX) is produced within the corpus luteum (CL; Steinetz et al. 1995 , Einspanier et al. 1997 , 1999 . Once the CL is formed, there is a steadily increasing level of RLX gene and protein expression throughout the luteal phase with a highest level in the CL of early pregnancy; whereas the regression CL shows a decline in RLX expression (Einspanier et al. 1997) . The fact that RLX is an important factor for CL maintenance could be supported by the significant increase in peripheral RLX levels in conceptive cycles compared with the nonconceptive cycles (Einspanier et al. 1999) , suggesting a possible role for RLX in the maintenance and establishment of the CL during early pregnancy. A recently published paper provided strong evidence that RLX is an important factor for the implantation of the blastocyst in the common marmoset monkey (Einspanier et al. 2009 ), because both RLX and its receptor are highly upregulated in the uterus during the time of implantation. Since the plasma concentrations of RLX remain relatively low (1 ng/ml) throughout implantation in primates, we hypothesized that RLX may act in a paracrine fashion in the CL and the placenta. While the role of RLX in parturition (uterine source) is well described, the diverse actions of RLX in the CL are still unknown. The role of RLX in the CL needs further investigation, especially in light of the newly described functions of RLX. The novel functions include RLX as a promoter of the decidualization of the endometrial stromal cells (Bani et al. 1995) , as a stimulant of angiogenesis in the uterus (Unemori et al. 1999) and as a remodelling factor for the extracellular matrix (Samuel et al. 2007 ). This remodelling action of RLX has been reported for different organs, such as the reproductive tract (Bryant-Greenwood et al. 2007) , kidneys (Samuel et al. 2007) , heart (Dschietzig et al. 2006) , arteries (Novak et al. 2006 ) and mammary glands (Binder et al. 2004) . A similar function of RLX in CL maintenance is therefore conceivable.
Although chorionic gonadotrophin (CG) seems to be of fundamental importance for human pregnancy (Keay et al. 2004) , it is only one of the factors necessary for a healthy pregnancy. In humans, 62% of the pregnancies diagnosed with increased CG do not reach term (Edmonds et al. 1982) . Therefore, the aim of the present study was to examine the local effect of RLX on the secretion of ovarian steroid hormones. We examined this effect by perfusing an explant of a CL from a common marmoset monkey with RLX during different stages of the luteal phase using an in vitro microdialysis system (MDS). Furthermore, our studies examined whether the luteal secretions of steroid hormones and RLX are influenced by the gonadotrophins. These gonadotrophins include human CG (hCG) and FSH. The MDS is a wellestablished system, which has been used in many species for investigating the autocrine and paracrine mechanisms in the CLs, for which cell-to-cell contacts are a paramount feature allowing proper function.
Previously, the MDS has been used in human (Maas et al. 1992) , primate (Einspanier & Hodges 1994 , Fehrenbach et al. 1995 , 1999 , porcine (Jarry et al. 1990 , Einspanier et al. 1991 and bovine studies (Miyamoto & Schams 1991 , Schams 1992 , Beindorff et al. 2009 ).
Results

Dialyzed corpora lutea
We used CLs of the mid-luteal phase (days 11-13) and late luteal phase (days 14-15) as well as regressing CLs (days 14-17) and CLs of pregnancy (days 15-40). A detailed assignment of the CLs to the luteal phases is described in the Materials and Methods part. Morphological examinations of the perfused tissue samples, which were harvested after 8.3 h of the MDS experiments, showed an intimate association of the perfusion membrane with the luteal tissue (Fig. 1A) . The luteal cells that were juxtaposed to the microdialysis membrane were visually intact and intensively stained for 3b-hydroxysteroid dehydrogenase (HSD3B, Fig. 1B-D) activity; however, the cells of the CL that were at an advanced regression stage did not show HSD3B staining.
Over the dialysis period of 8.3 h, all the control CLs showed a steady progesterone (P 4 ) and oestradiol (E 2 ) secretion (data not shown), which demonstrates the validity of luteal explants in in vitro MDS experiments. The baseline P 4 secretion (meansGS.D.) of the perfused CLs was 73G35, 83G29 and 45G34 pg/ml during the mid-luteal phase, late luteal phase and regression respectively. The E 2 secretion was 199G132, 157G24 and 195G110 pg/ml respectively.
There was no significant correlation between plasma P 4 and baseline P 4 secretion of the CLs (nZ13 animals, correlation coefficientZ0.406, PZ0.168); moreover, there was no significant correlation between plasma E 2 and baseline E 2 secretion of the CLs (nZ14 animals, correlation coefficient ZK0.045, PZ0.877).
Relaxin application
In general, we observed a significant effect of RLX on P 4 and E 2 hormone secretion in the CL. During the midluteal phase, RLX applications of 250, 500 and 1000 ng/ml resulted in a progressive increase in the secretion of P 4 compared with the baseline levels. RLX applications of 250, 500 and 1000 ng/ml increased luteal secretion of P 4 by 38G44% (PZ0.187, nZ4), 54G42% (PZ0.045, nZ5) and 102G86% (PZ0.058, nZ5) respectively (Fig. 2) . The most likely time for implantation is around day 11 after ovulation, which corresponds with the mid-luteal phase. During this time, we found that the highest RLX dose (1000 ng/ml) resulted in the highest mean P 4 secretion (102%); however, ANOVA did not show significant differences between the effects of the various RLX dosages on P 4 secretion. On days 14 and 15 of the luteal phase, all the different RLX concentrations resulted in significant increases in P 4 secretion compared with the baseline levels (250 ng/ml: 53G10%, PZ0.012, nZ3; 500 ng/ml: 44G15%, PZ0.039, nZ3; 1000 ng/ml: 62G15%, PZ0.018, nZ3). In the regressed CL, RLX application caused a significant change in P 4 secretion only when 500 ng/ml of RLX was used (250 ng/ml: 20G31%, PO0.05, nZ3; 500 ng/ml: 18G15%, PZ0.035, nZ6; 1000 ng/ml: 43G63%, PZ0.153, nZ6). Importantly, in all CL stages, no significant differences were observed in P 4 secretion between the baseline levels just before the RLX applications of 250, 500 and 1000 ng/ml and the secretion levels after the end of the RLX applications (data not shown).
During the RLX applications, the increase in E 2 secretion by the CL was less pronounced than the increase in P 4 secretion (Fig. 3) . In contrast to the effect of RLX on P 4 secretions, the response in E 2 secretion appeared to be more sensitive to RLX as the lowest concentration had already evoked the maximal, but not significant, response in the mid-luteal phase CL (250 ng/ml: 31G24%, PZ0.157, nZ3; 500 ng/ml: 24 G11%, PZ0.009, nZ5; 1000 ng/ml: 16G13%, PZ0.050, nZ5). However, the resulting differences between the effects of the various dosages of RLX on E 2 secretion did not reach the level of significance (ANOVA, PO0.05). During the late luteal phase, only 1000 ng/ml RLX (18G7%, PZ0.042, nZ3) had a significant effect on E 2 secretion. During regression, no significant changes in E 2 secretion were observed irrespective of the RLX concentration (250 ng/ml: 5G20%, PO0.05, nZ3; 500 ng/ml: 3G28%, PO0.05, nZ6; 1000 ng/ml: 11G27%, PO0.05, nZ6). In contrast to the secretion of P 4 , a prolonged rise in E 2 secretion could be observed in the mid-luteal phase CL after the end of 1000 ng/ml RLX application (9G7%, PZ0.045), and in the regressed CL after the end of 500 ng/ml RLX application (10G6%, PZ0.009) compared with the baseline levels. In all other cases, no prolonged rise in E 2 was detectable after the end of RLX application (data not shown).
Gonadotrophin application
The influence of the gonadotrophins hCG and FSH on luteal hormone secretion was tested from early pregnancy through day 40 of pregnancy ( Fig. 4) . We found that recombinant human FSH had a significant luteotrophic effect on both P 4 (20G8%, PZ0.009, nZ5) and E 2 (37G28%, PZ0.018, nZ5) secretions. On the other hand, hCG did not have a significant effect on P 4 (9G17%, PO0.05, nZ3) or on E 2 (26G15%, PO0.05, nZ3) secretion. There was a prominent rise in RLX secretion (239G334%, PO0.05, nZ3) during FSH application; however, this was not statistically significant. This is probably due to the high variability in the results in G29 pg/ml and regressionZ45G34 pg/ml). Plasma P 4 concentration for each luteal phase was midZ395G276 ng/ml, lateZ225
G118 ng/ml and regressionZ83G34 ng/ml. Mid luteal Late luteal Regression * * * 250 ng/ml RLX 500 ng/ml RLX 1000 ng/ml RLX Figure 3 E 2 release from in vitro microdialyzed CLs during the mid-luteal (days 11-13) and late luteal (days 14 and 15) phases and luteal regression (days 14-17) when perfused with RLX for 1 h (nZmid/late/regression: 250 ng/ml nZ3/3/3; 500 ng/ml nZ5/3/6; 1000 ng/ml nZ5/3/6). All values are shown as change in secretion in percentage of the respective pooled baseline (meansGS.D). Values with an asterisk (*) are different (P%0.05) in comparison with the baseline levels (meansGS.D. baseline E 2 release: midZ199G132 pg/ml, lateZ157G24 pg/ml and regressionZ195G110 pg/ml). Plasma E 2 concentration for each luteal phase was midZ0.50G0.32 ng/ml, lateZ0.51G0.50 ng/ml and regressionZ0.47G0.24 ng/ml. 
Discussion
In this study, we showed that RLX has a luteotrophic action on in vitro microdialyzed marmoset CLs throughout the different stages of the luteal phase. The highest RLX-induced P 4 secretions occurred in the mid-luteal and late luteal phase CLs, which is important because the mid-luteal phase is the most likely time for the implantation to occur. Whereas the adaptable nature of the CL begins to regress with tissue reorganization during the late luteal phase, it retains a functional lifespan during pregnancy of w144 days in the common marmoset monkey. Despite being less pronounced, the E 2 response to RLX in the mid-luteal phase CL was more sensitive than that of P 4 , as even the lower RLX dosages gave a maximal response compared with the highest RLX dosage, which resulted in the lowest response. This sensitivity of E 2 under RLX application seems to be necessary for successful implantation, while the balanced and temporal secretion of this steroid is important for angiogenesis and immunotolerance (Segerer et al. 2008) .
Multiple studies have shown that P 4 from the CL is required to maintain early pregnancy. P 4 has many roles, one of which is the remodelling of the proliferating endometrium, where RLX is also involved. The importance of luteal RLX in the marmoset is also implied by circulating RLX levels: low levels are observed during the follicular phase and increasing levels are observed during the luteal phase. Moreover, significantly higher RLX levels are detectable during the mid-luteal and late luteal phases of animals in conceptive cycles compared with the animals in the non-conceptive cycles (Einspanier et al. 1999) . These results are in accordance with our MDS data, suggesting that sufficient levels of ovarian RLX must be secreted during the mid-luteal and late luteal phases in order to allow appropriate placental development and implantation of the blastocyst. The luteotrophic stimulus of RLX may augment the local effects of P 4 on luteal cells, such as the suppression of apoptosis to maintain CL function (Okuda et al. 2004) and activation of angiogenesis (Jeyabalan et al. 2007) .
Moreover, P 4 also induces immunotolerance (Segerer et al. 2008) , which can be further modulated by oestrogens (Segerer et al. 2008) . Therefore, the luteal E 2 produced in our mid-luteal and late luteal phasedialyzed CLs during RLX application is likely to have an additive effect on the immunotolerance. Ravindranath & Moudgal (1990) demonstrated that oestrogens are necessary for a successful establishment of pregnancy during the peri-implantation period in the bonnet monkey (Macaca radiata). Adding E 2 to P 4 for luteal support resulted in a significant increase in implantation and pregnancy rates in human patients undergoing IVF cycles (Farhi et al. 2000) . Luteal effects of E 2 in the marmoset monkey are supported by the presence of the oestrogen receptor in the ovaries (Saunders et al. 2000) and the expression of 17b-hydroxysteroid dehydrogenase type 7 (HSD17B7) in the CL (Husen et al. 2003) , an enzyme which converts oestrone to E 2 .
Another enzyme for steroidogenesis, HSD3B, which is necessary for P 4 synthesis, was also detectable in the dialyzed CL at the end of the perfusion, supporting the idea that luteal tissues are still functional after MDS experiments. Cellular integrity of marmoset CLs following MDS experiments was also observed by electron microscopy, where luteal cells lying in a sheath of five to seven cell layers around the dialysis tubing were shown to be intact and interconnected by gap junctions (Fehrenbach et al. 1995) .
Despite the parallel increases in RLX and CG levels during early pregnancy, the precise relationship between both hormones is still uncertain. Exogenous applications of hCG to women (Quagliarello et al. 1980) or rhesus monkeys (Ottobre et al. 1984 , Duffy et al. 1996 resulted in an increase in RLX secretion, which was partly delayed. These results contrast the findings obtained here as well as those reported for human luteal cell culture experiments (Schmidt et al. 1986) or the in vivo studies with marmosets (Einspanier et al. 1999) failing to demonstrate hCG-induced RLX secretion. This inconsistency may indicate that a constant hCG Values with an asterisk (*) are different (P%0.05) in comparison with the baseline levels (meanGS.D. baseline release: P 4 Z118G29 pg/ml, E 2 Z55G21 pg/ml and RLXZ23G3 pg/ml). Plasma concentration of P 4 was 598G150 ng/ml and of E 2 was 0.64G0.42 ng/ml.
influence is needed, and that different CG preparations, purity or concentrations have been used. While treatment of CLs with hCG did not affect the RLX, P 4 or E 2 secretion, the application of FSH resulted in a significant increase in both P 4 and E 2 secretions during the dialysis of the early pregnant CLs. Moreover, FSH provoked a high, but statistically not significant, increase in RLX secretion. The high sample variability might be caused by CLs being taken from animals, which were in the range of days 15-40 of pregnancy. Thus, our results clearly demonstrate that FSH acts as a gonadotrophin with a luteotrophic effect, and that FSH has a function beyond its conventional allocation as a FSH only, as suggested by several authors, e.g. Kumar (2009) . This assumption is supported by the detection of the FSH receptor in the human CL (Minegishi et al. 1997) . Furthermore, bioactive FSH levels were shown to be elevated only in the mid-luteal to late luteal phase of the human menstrual cycle (Christin-Maitre et al. 1996) . Therefore, it seems likely that FSH takes over some LH functions in the primate CL. For example, in the hamster, FSH stimulates the LH receptors in the CL (Yuan et al. 1995) , and FSH as well as LH stimulates P 4 production in hamster luteal cells (Yuan et al. 1995) .
To discuss the high sample variability conclusively, we also calculated alongside the present analysis (relative change in secretion in percentage) the absolute change in secretion in pg/ml. Both methods yielded similar results; however, stronger significance was obtained by the results of the relative changes. However, a high variability still occurred, which might be due to interindividual endocrine variation or the range of days of luteectomy for each group, and therefore, different maturations of the CL. Interestingly, the plasma steroid concentrations of each marmoset also show this high variability within each group. In conclusion, our results demonstrate that the CL responds to RLX by secretion of P 4 and E 2 during the mid-luteal and late luteal phases. We propose that RLX and E 2 support early pregnancy in conjunction with P 4 to orchestrate the processes that allow for successful implantation, and to retain a functional CL thereafter. Our findings also highlight the role of FSH by stimulating the secretion of P 4 and E 2 in the marmoset CL during early pregnancy, suggesting that FSH may perform some of the functions usually ascribed to LH in other mammals.
Materials and Methods
Animals
Female marmoset monkeys (C. jacchus; nZ17; meanGS.D., age 5.0G1.8 years, body weight 427G66 g) were paired with male partners. Animals were housed in individual cages under controlled and standardized conditions (12 h light:12 h darkness; temperature 25 8C and humidity 63%) at the German Primate Centre (Gö ttingen, Germany). The nutrition for the monkeys was provided in the form of marmoset pellets (SSNIFF, Soest, Germany) in combination with seasonal fruits and vegetables.
The marmoset monkey is a polyovulatory species (Tardif et al. 1993 ) with a cycle length of 28 days (10 days of follicular phase, 18 days of luteal phase, term of pregnancy w144 days; Hodges et al. 1983 ). On average, implantation occurs on day 11 after ovulation (Hearn et al. 1988) . For the ovarian cycle analysis and pregnancy detection, 0.2-ml blood samples were taken from the vena femoralis twice per week. Plasma P 4 concentrations were determined by direct enzyme immunoassay (Heistermann et al. 1993 (Heistermann et al. , 1998 in order to monitor the ovarian cycles. Ovulation occurs shortly before the P 4 level rises above 10 ng/ml (Harlow et al. 1984) . A luteolytic dosage of prostaglandin F 2a (0.8 mg cloprostenol, Estrumate; PitmanMoore Inc., Mundelein, IL, USA) was administered between days 10 and 14 of the luteal phase to induce luteolysis, and to help identify the timing of the subsequent ovulation accurately (Summers et al. 1985) . Before the start of the experiments, the ovaries and the uterus were examined and measured by ultrasound using a transducer with 11-13 MHz (Logiq 400; General Electrics, Fairfield, CT, USA) as described previously by Einspanier et al. (2006) .
All animal experiments were approved by the local ethics committee for animal rights protection Brunswick, Germany, in accordance with German legislation on animal rights and welfare (file reference number 509.42502/0803.99).
Tissue collection
As the marmoset is polyovulatory, two or three CLs are usually present in each cycle. Therefore, if possible, the CLs of an individual animal were allocated to each of the three different RLX concentrations or gonadotrophins as described in the following paragraph 'in vitro MDS'. The collection of the CLs (nZ46 from 17 animals) was carried out between days 11 and 17 during the luteal phase or till day 40 of early pregnancy. The animals were sedated with an i.m. injection containing a mixture of ketamine (Parke Davis, USA; 5 mg/350 g body weight) and xylazine (Rompun, Bayer; 1 mg/350 g body weight), and narcotized with a halothane-nitrous oxideoxygen mixture (Baxter, Unterschleißheim, Germany). Laparotomy was performed, and the tissue was removed by luteectomy as described by Webley et al. (1989) . The CLs were staged retrospectively to the different luteal phases by plasma P 4 determination twice per week after ovulation, and the ensuing analysis of the plasma P 4 on the day of luteectomy. Stable or increasing plasma P 4 concentrations after at least 10 days of ovulation dated the explanted CLs to the mid-luteal or late luteal phase. Declining P 4 concentrations presented regressing CLs at least 14 days after ovulation. On the day of luteectomy, the meanGS.D. plasma P 4 concentration was 395G276, 225G118 and 83G34 ng/ml for the mid-luteal phase (days 11-13), late luteal phase (days 14-15) and regression (days 14-17) respectively. Pregnancy (days 15-40) could be detected with ultrasound as early as day 15, as pregnant monkeys exhibit an increased uterus lumen from day 15 forward (Nubbemeyer et al. 1997) . 
In vitro MDS
Each CL with a size of about 4!5!5 mm was penetrated with a 3.5-mm-long dialysis capillary (Amicon Diafilter 20, : 250 mm, molecular weight cut-off 30 000-50 000 kDa; Amicon, Beverly, MA, USA) with each end attached to a silicone tubing. The silicone tubing was fixed on the face of the luteal piece with tissue glue (Tissucol Dou S Immuno, Baxter). For the perfusion, one of the tubes was connected to a peristaltic pump, and the other was joined to the fraction collector. Luteal pieces thus prepared were maintained in organ culture chambers filled with 15 ml Medium 199 (Gibco BRL, Life Technologies) at 37 8C on a heating plate. Medium 199 was continuously exchanged at a flow rate of 6 ml/h. During the incubation, luteal pieces were perfused with Ringer's solution supplemented with 0.5 mg/ml low-density lipoprotein (LDL, Sigma) at a flow rate of 3 ml/h for 8.3 h (Fig. 5) . After 3 h of pre-incubation, the CLs stabilized their basal secretions. The mean concentrations of the four fractions (20 min collection time for each) that were taken after the preincubation but before the application of the test substances (three fractions of RLX and two fractions of gonadotrophins) were used for the baseline value calculation for each perfused CL. All hormone concentrations in the collected fractions were then expressed as a percentage of this individual baseline value. Porcine RLX (courtesy of Prof. Dr O D Sherwood, University of Illinois, Chicago, IL, USA) was dissolved in Ringer's solution at the following concentrations: 250, 500 and 1000 ng/ml. Recombinant human FSH (FSH 509 G; Akzo Nobel, Leverkusen, Germany) and recombinant hCG (WK hCG150 Akzo Nobel) were dissolved at a concentration of 50 IU/ml each. These solutions were stored at K20 8C until used in the MDS experiment. Because of the low transfer rate of the dialysis capillary (w1%), it was necessary to use these high concentrations of the test substances to reach physiological concentrations in the luteal tissues (Einspanier & Hodges 1994) . After the application of the test substances, the CLs were dialyzed for another 3 h to observe the secretion pattern after the application of the test substances. To check the validity of the luteal explants in the MDS experiment, seven control CLs were dialyzed with Ringer's solution and LDL only. The collected fractions were stored at K20 8C until analyzed by direct enzyme immunoassay for P 4 , E 2 and RLX (Heistermann et al. 1993 , 1998 , Einspanier et al. 1999 . RLX was only examined in the group of CLs where we examined luteal stimulation by the gonadotrophins. To control the half-life of RLX, all RLX test substances of each experimental run were analyzed in the RLX assay thereafter. After perfusion, the CLs were fixed in 3.7% neutral buffered formalin. The functional integrity of the tissue was confirmed histologically by haematoxylin and eosin staining, and immunohistochemically by examining the protein expression of HSD3B in the cytoplasm, one of the essential enzymes in the P 4 synthesis pathway. A detailed description of processing and sectioning of the tissue samples has been published by Einspanier et al. (1997) .
Statistical analysis
All hormone values presented in the text are given as meanG1 S.D. of the indicated groups' data. An unpaired, two-tailed Student's t-test was used to evaluate the statistical differences between two groups, while a one-way ANOVA was used for testing for differences between more than two subgroups. For all tests, a P%0.05 was considered statistically significant.
In order to test for potential correlation between plasma P 4 and baseline P 4 secretion of the perfused CL, measurements of P 4 secretion at baseline were averaged over all CLs and all fractions in each animal. Pearson's correlation analysis was performed including all animals irrespective of the group. Test for correlation between plasma E 2 and baseline E 2 secretion of the CLs was performed analogously.
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